PTC-510 (free base)
Product Specifications
UNSPSC Description
PTC-510 Free base is a compound that selectively inhibits hypoxia-induced VEGF expression in tumor cells. PTC-510 Free base demonstrates potent activity in reducing endogenous VEGF production under hypoxic conditions. PTC-510 Free base has been shown to control tumor growth effectively while minimizing toxicity. PTC-510 Free base represents a novel therapeutic strategy to address the limitations of current anti-VEGF therapies.
Target Antigen
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ptc-510-free-base.html
Smiles
O=C(N1C2CCCCC2)C3CC4=C(NC5=C4C=C(C=C5)Br)C(N3C1=S)C6=CC=C(C=C6)OC
Molecular Weight
524.47
References & Citations
[1]Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125059/PTC-510-free-base-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125059/
Clinical Information
No Development Reported
CAS Number
865531-74-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
